Institutional investors purchased a net $16.6 million shares of RNN during the quarter ended September 2015, and now own 14.09% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EMPERY ASSET MANAGEMENT LP Bought 16.7 Million shares of Rexahn Pharmaceuticals In...